Related references
Note: Only part of the references are listed.Spinal Cord Atrophy Predicts Progressive Disease in Relapsing Multiple Sclerosis
Antje Bischof et al.
ANNALS OF NEUROLOGY (2022)
Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study
Pascal Benkert et al.
LANCET NEUROLOGY (2022)
Association of Slowly Expanding Lesions on MRI With Disability in People With Secondary Progressive Multiple Sclerosis
Alberto Calvi et al.
NEUROLOGY (2022)
Disease correlates of rim lesions on quantitative susceptibility mapping in multiple sclerosis
Melanie Marcille et al.
SCIENTIFIC REPORTS (2022)
A candidate biomarker of glial fibrillary acidic protein in CSF and blood in differentiating multiple sclerosis and its subtypes: A systematic review and meta-analysis
MengJiao Sun et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2021)
Cholesterol and neurodegeneration: longitudinal changes in serum cholesterol biomarkers are associated with new lesions and gray matter atrophy in multiple sclerosis over 5 years of follow-up
N. Murali et al.
EUROPEAN JOURNAL OF NEUROLOGY (2020)
Apolipoproteins AI and E are associated with neuroaxonal injury to gray matter in multiple sclerosis
Mason McComb et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
Increased level of fibrinogen chains in the proteome of blood platelets in secondary progressive multiple sclerosis patients
Michal Bijak et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
Alan J. Thompson et al.
LANCET NEUROLOGY (2018)
Alpha-2 macroglobulin in Alzheimer's disease: a marker of neuronal injury through the RCAN1 pathway
V. R. Varma et al.
MOLECULAR PSYCHIATRY (2017)
Age Related Multiple Sclerosis Severity Score: Disability ranked by age
Ali Manouchehrinia et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Age Related Multiple Sclerosis Severity Score: Disability ranked by age
Ali Manouchehrinia et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
New Multiple Sclerosis Disease Severity Scale Predicts Future Accumulation of Disability
Ann Marie Weideman et al.
FRONTIERS IN NEUROLOGY (2017)
CSF Proteomics Identifies Specific and Shared Pathways for Multiple Sclerosis Clinical Subtypes
Timucin Avsar et al.
PLOS ONE (2015)
Alteration of prolyl oligopeptidase and activated α-2-macroglobulin in multiple sclerosis subtypes and in the clinically isolated syndrome
Jofre Tenorio-Laranga et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Analyses of haptoglobin level in the cerebrospinal fluid and serum of patients with neuromyelitis optica and multiple sclerosis
Kuo-Hsuan Chang et al.
CLINICA CHIMICA ACTA (2013)
Application of data mining techniques for detecting asymptomatic carotid artery stenosis
Ugur Bilge et al.
COMPUTERS & ELECTRICAL ENGINEERING (2013)
Diagnostic Criteria for Multiple Sclerosis: 2010 Revisions to the McDonald Criteria
Chris H. Polman et al.
ANNALS OF NEUROLOGY (2011)
Clinico-pathological evidence that axonal loss underlies disability in progressive multiple sclerosis
Emma C. Tallantyre et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
Diagnostic criteria for multiple sclerosis: 2005 Revisions to the McDonald Criteria
CH Polman et al.
ANNALS OF NEUROLOGY (2005)
Native and transformed α2-macroglobulin in plasma from patients with multiple sclerosis
M Gunnarsson et al.
ACTA NEUROLOGICA SCANDINAVICA (2003)
Oligodendrocyte injury in multiple sclerosis:: a role for p53
K Wosik et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Blood-brain barrier disruption in multiple sclerosis
A Minagar et al.
MULTIPLE SCLEROSIS JOURNAL (2003)
Apolipoprotein A-I inhibits the production of interleukin-1β and tumor necrosis factor-α by blocking contact-mediated activation of monocytes by T lymphocytes
N Hyka et al.
BLOOD (2001)
Role of haptoglobin in free hemoglobin metabolism
SK Lim et al.
REDOX REPORT (2001)
Share Paper
